Answers are grounded in this paper and cite their sources.
Microfluidic organ-on-a-chip (OoC) platforms enable dynamic modeling of human tissue physiology under controlled perfusion, yet most rely on endpoint assays or fluorescence-based probes with limited spatiotemporal resolution. Quantum biosensing technologies including semiconductor quantum dots, and atom-based magnetometers offer nanoscale sensitivity to magnetic, optical, thermal, and chemical signals with minimal invasiveness. This Perspective examines the integration of quantum biosensors directly into microfluidic OoC substrates to enable continuous, label-free monitoring of electrophysiology, metabolic activity, and microenvironmental gradients. We discuss miniaturization limits, optical and microwave delivery constraints, thermal management, multiplexed signal processing, and machine-learning requirements for high-dimensional data interpretation. We outline application-driven pathways in cardiac-, neural-, and tumor-on-chip systems and propose engineering strategies toward hybrid quantum OoC platforms for high-resolution preclinical testing and adaptive therapeutic screening.
No takes yet. Share an insight, caveat, or question.
Subham Preetam (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: